Mendus
Developing immunotherapies using dendritic cells to prevent recurrence of AML & ovarian cancer.
IMMU | ST
Overview
Corporate Details
- ISIN(s):
- SE0005003654 (+1 more)
- LEI:
- 529900AFBGFR7ZB50J95
- Country:
- Sweden
- Address:
- Västra Trädgårdsgatan 15, 111 53 Stockholm
- Website:
- https://mendus.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Mendus is a clinical-stage biotechnology company dedicated to changing the course of cancer treatment by developing immunotherapies that address tumor recurrence. The company's approach focuses on exploring the power of the immune system to build active immunity against residual cancer cells, aiming to improve long-term survival and quality of life for patients. A leader in allogeneic dendritic cell biology, its lead product candidate, vididencel, is advancing through clinical trials for indications such as ovarian cancer and acute myeloid leukemia (AML). Mendus was formerly known as Immunicum.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Mendus and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-21 08:00 |
Quarterly Report
|
Swedish | 1.4 MB | |
| 2025-08-21 08:00 |
Quarterly Report
|
English | 1.4 MB | |
| 2025-08-20 18:00 |
Transaction in Own Shares
Mendus AB (publ) has resolved to transfer own shares on Nasdaq Stockholm
|
English | 117.2 KB | |
| 2025-08-20 18:00 |
Transaction in Own Shares
Mendus AB (publ) har beslutat om överlåtelse av egna aktier
|
Swedish | 117.4 KB | |
| 2025-06-30 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Mendus AB (publ)
|
Swedish | 124.2 KB | |
| 2025-06-30 08:00 |
Share Issue/Capital Change
Change in number of shares and votes in Mendus AB (publ)
|
English | 123.6 KB | |
| 2025-05-26 17:50 |
Remuneration Information
Mendus AB (publ) har beslutat om emission av C-aktier och överlåtelse av egna s…
|
Swedish | 117.6 KB | |
| 2025-05-26 17:50 |
Share Issue/Capital Change
Mendus AB (publ) has decided on directed issues of Class C shares and transfer …
|
English | 118.1 KB | |
| 2025-05-06 10:10 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i Mendus AB (publ) den 6 maj 2025
|
Swedish | 128.6 KB | |
| 2025-05-06 10:10 |
Post-Annual General Meeting Information
Report from the Annual General Meeting of Mendus AB (publ) on 6 May 2025
|
English | 128.9 KB | |
| 2025-05-06 08:00 |
Earnings Release
|
Swedish | 1.4 MB | |
| 2025-05-06 08:00 |
Quarterly Report
|
English | 1.4 MB | |
| 2025-02-13 08:00 |
Earnings Release
|
Swedish | 1.5 MB | |
| 2025-02-13 08:00 |
Annual Report
|
English | 1.5 MB | |
| 2024-08-23 08:00 |
Earnings Release
|
Swedish | 1.3 MB |
Automate Your Workflow. Get a real-time feed of all Mendus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Mendus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Erik Manting | Other | Buy | 7,780 | 56,249.40 SEK |
| 2025-03-11 | Erik Manting | Other | Buy | 7,780 | 55,704.80 SEK |
| 2025-02-25 | Sven Arne Andreasson | Other | Buy | 25,000 | 198,750.00 SEK |
| 2024-04-02 | Erik Manting | Other | Other | 885,648 | 425,111.04 SEK |
| 2024-04-02 | Dharminder Chahal | Other | Other | 882,048 | 423,383.04 SEK |
| 2024-04-02 | Leopold Bertea | Other | Other | 267,858 | 128,571.84 SEK |
| 2022-10-25 | Sven Arne Andreasson | Other | Sell | 15,000 | 31,950.00 SEK |
| 2022-10-12 | Sven Arne Andreasson | Other | Sell | 10,000 | 18,800.00 SEK |
| 2022-05-20 | Erik Manting | Other | Buy | 37,059 | 86,347.47 SEK |
| 2022-05-19 | Ann-Charlotte Ferm | Other | Buy | 100,000 | 215,900.00 SEK |
